Free access
Issue
Vet. Res.
Volume 41, Number 2, March–April 2010
Number of page(s) 15
DOI http://dx.doi.org/10.1051/vetres/2009067
Published online 29 October 2009
How to cite this article Vet. Res. (2010) 41:19
References of  Vet. Res. (2010) 41:19
  1. Barquero N., Daly J.M., Newton J.R., Risk factors for influenza infection in vaccinated racehorses: lessons from an outbreak in Newmarket, UK in 2003, Vaccine (2007) 25:7520–7529 [PubMed] [CrossRef].
  2. Bryant N.A., Rash A.S., Russell C.A., Ross J., Cooke A., Bowman S., et al., Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007, Vet. Microbiol. (2009) 138:41–52 [PubMed] [CrossRef].
  3. Cook R.F., Sinclair R., Mumford J.A., Detection of influenza nucleoprotein antigen in nasal secretions from horses infected with A/equine influenza (H3N8) viruses, J. Virol. Methods (1988) 20:1–12 [PubMed] [CrossRef].
  4. Cullinane A., Weld J., Osborne M., Nelly M., McBride C., Walsh C., Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings, Vet. J. (2001) 161:174–185 [PubMed] [CrossRef].
  5. Daly J.M., Lai A.C., Binns M.M., Chambers T.M., Barrandeguy M., Mumford J.A., Antigenic and genetic evolution of equine H3N8 influenza A viruses, J. Gen. Virol. (1996) 77:661–671 [PubMed] [CrossRef].
  6. Daly J.M., Yates R.J., Browse G., Swann Z., Newton J.R., Jessett D., et al., Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines, Equine Vet. J. (2003) 35:458–462 [PubMed] [CrossRef].
  7. Daly J.M., Yates P.J., Newton J.R., Park A., Henley W., Wood J.L., et al., Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines, Vaccine (2004) 22:4101–4109 [PubMed] [CrossRef].
  8. Daly J.M., Sindle T., Tearle J., Barquero N., Newton J.R., Corning S., Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study, Equine Vet. J. (2007) 39:446–450 [PubMed] [CrossRef].
  9. East I.J., The role of land use patterns in limiting the spread of equine influenza in Queensland during the 2007 epidemic, Transbound. Emerg. Dis. (2009) 56:292–302 [CrossRef].
  10. Edlund Toulemonde C., Daly J., Sindle T., Guigal P.M., Audonnet J.C., Minke J.M., Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom, Vet. Rec. (2005) 156:367–371 [PubMed].
  11. Hannant D., Mumford J.A., Jessett D.M., Duration of circulating antibody and immunity following infection with equine influenza virus, Vet. Rec. (1988) 122:125–128 [PubMed].
  12. Heldens J.G., Kersten A.J., Weststrate M.W., van den Hoven R., Duration of immunity induced by an adjuvanted and inactivated equine influenza, tetanus and equine herpesvirus 1 and 4 combination vaccine, Vet. Q. (2001) 23:210–217 [PubMed].
  13. Heldens J.G., Pouwels H.G., van Loon A.A., Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95), Vet. J. (2004) 167:150–157 [PubMed] [CrossRef].
  14. Ito M., Nagai M., Hayakawa Y., Komae H., Murakami N., Yotsuya S., et al., Genetic analyses of an H3N8 influenza virus isolate, causative atrain of the outbreak of equine influenza at the Kanazawa racecourse in Japan in 2007, J. Vet. Med. Sci. (2008) 70:899–906 [PubMed] [CrossRef].
  15. Kucera C.J., Beckenhauer W.H., Studies on the antigenicity of an inactivated, aluminum hydroxide adjuvant equine influenza vaccine, Can. J. Comp. Med. (1977) 41:326–331 [PubMed].
  16. Lai A.C., Chambers T.M., Holland R.E. Jr, Morley P.S., Haines D.M., Townsend H.G., Barrandeguy M., Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere, Arch. Virol. (2001) 146:1063–1074 [PubMed] [CrossRef].
  17. Martella V., Elia G., Decaro N., Di Trani L., Lorusso E., Campolo M., et al., An outbreak of equine influenza virus in vaccinated horses in Italy is due to an H3N8 strain closely related to recent North American representatives of the Florida sub-lineage, Vet. Microbiol. (2007) 121:56–63 [PubMed] [CrossRef].
  18. McMichael A.J., Gotch F.M., Noble G.R., Beare P.A., Cytotoxic T-cell immunity to influenza, N. Engl. J. Med. (1983) 309:13–17 [PubMed].
  19. Minke J.M., Toulemonde C.E., Coupier H., Guigal P.M., Dinic S., Sindle T., et al., Efficacy of a canarypoxvectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge, Am. J. Vet. Res. (2007) 68:213–219 [PubMed] [CrossRef].
  20. Mumford J., Wood J.M., Scott A.M., Folkers C., Schild G.C., Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8), J. Hyg. (Lond.) (1983) 90:385–395 [PubMed].
  21. Mumford J.A., Wood J.M., Folkers C., Schild G.C., Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus, Epidemiol. Infect. (1988) 100:501–510 [PubMed] [CrossRef].
  22. Mumford J.A., Wood J., Establishing an acceptability threshold for equine influenza vaccines, Dev. Biol. Stand. (1992) 79:137–146 [PubMed].
  23. Mumford J.A., Jessett D.M., Rollinson E.A., Hannant D., Draper M.E., Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines, Vet. Rec. (1994) 134:158–162 [PubMed].
  24. Newton J.R., Wood J.L., Dunn K.A., DeBrauwere M.N., Chanter N., Naturally occurring persistent and asymptomatic infection of the guttural pouches of horses with Streptococcus equi, Vet. Rec. (1997) 140:84–90 [PubMed].
  25. Newton J.R., Daly J.M., Spencer L., Mumford J.A., Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease, Vet. Rec. (2006) 158:185–192 [PubMed].
  26. Paillot R., Hannant D., Kydd J.H., Daly J.M., Vaccination against equine influenza: quid novi?, Vaccine (2006) 24:4047–4061 [PubMed] [CrossRef].
  27. Paillot R., Kydd J.H., Sindle T., Hannant D., Edlund Toulemonde C., Audonnet J.C., et al., Antibody and IFNgamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus, Vet. Immunol. Immunopathol. (2006) 112:225–233 [PubMed] [CrossRef].
  28. Paillot R., Kydd J.H., MacRae S., Minke J.M., Hannant D., Daly J.M., New assays to measure equine influenza virus-specific Type 1 immunity in horses, Vaccine (2007) 25:7385–7398 [PubMed] [CrossRef].
  29. Paillot R., Grimmett H., Elton D., Daly J.M., Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host, Vet. Res. (2008) 39:21 [PubMed] [CrossRef] [EDP Sciences].
  30. Powell D.G., Burrows R., Spooner P., Mumford J., Thomson G., Field observations on influenza vaccination among horses in Britain, 1971–1976, Dev. Biol. Stand. (1977) 39:347–352 [PubMed].
  31. Sovinova O., Tumova B., Pouska F., Nemec J., Isolation of a virus causing respiratory disease in horses, Acta Virol. (1958) 2:52–61 [PubMed].
  32. Waddell G.H., Teigland M.B., Sigel M.M., A new influenza virus associated with equine respiratory disease, J. Am. Vet. Med. Assoc. (1963) 143:587–590 [PubMed].
  33. Webster R.G., Are equine 1 influenza viruses still present in horses?, Equine Vet. J. (1993) 25:537–538 [PubMed].
  34. Wood J.L., Mumford J.A., Mair T.S., Slater J., Boosting in equine influenza vaccination schedules: timing and time for a re-evaluation of requirements of national and international authorities, Vet. J. (2007) 174:449–450 [PubMed] [CrossRef].
  35. Wood J.M., Schild G.C., Folkers C., Mumford J., Newman R.W., The standardization of inactivated equine influenza vaccines by single-radial immunodiffusion, J. Biol. Stand. (1983) 11:133–136 [PubMed] [CrossRef].
  36. Yamanaka T., Niwa H., Tsujimura K., Kondo T., Matsumura T., Epidemic of equine influenza among vaccinated racehorses in Japan in 2007, J. Vet. Med. Sci. (2008) 70:623–625 [PubMed] [CrossRef].
  37. Yates P., Mumford J.A., Equine influenza vaccine efficacy: the significance of antigenic variation, Vet. Microbiol. (2000) 74:173–177 [PubMed] [CrossRef].